NEXI Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 14.90%

Insider Buying (Last 12 Months): $0.01

Insider Selling (Last 12 Months): $0.00

NexImmune Insider Trading History Chart

NexImmune Share Price & Price History

^$0.00

▼ -0.0001 (-100.00%)

As of 03/13/2025 01:00 AM ET

Days: 30 | 90 | 365

NexImmune Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/11/2024	Kristi Jones	CEO	Buy	1	$0.01	$0.01	1
11/21/2023	Alan S Roemer	Director	Sell	3,833	$2.16	$8,279.28	3,992
3/30/2023	Sol J Barer	Director	Buy	16,000	$10.25	$164,000.00	88,712
11/16/2022	Sol J Barer	Director	Buy	5,000	$12.00	$60,000.00	69,712
6/6/2022	Grant Verstandig	Director	Buy	1,000	$53.50	$53,500.00	43,144
6/2/2022	Grant Verstandig	Director	Buy	1,916	$55.75	$106,817.00	41,544
5/31/2022	Grant Verstandig	Director	Buy	1,800	$52.75	$94,950.00	38,020
3/29/2022	Kristi Jones	CEO	Buy	400	$93.50	$37,400.00
3/28/2022	Grant Verstandig	Director	Buy	759	$94.00	$71,346.00
3/24/2022	Grant Verstandig	Director	Buy	1,599	$83.75	$133,916.25
3/22/2022	Sol J Barer	Director	Buy	1,200	$60.25	$72,300.00
3/18/2022	Sol J Barer	Director	Buy	1,200	$52.75	$63,300.00

SEC Filings (Institutional Ownership Changes) for NexImmune (NASDAQ:NEXI)

9.85% of NexImmune stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

NexImmune Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/22/2024	PNC Financial Services Group Inc.	12,640	$28K	0.0%	-96.0%	1.192%
5/16/2023	Slate Path Capital LP	925,000	$0.35M	0.0%	N/A	3.547%
4/26/2023	Caprock Group LLC	103,482	$39K	0.0%	+82.9%	0.397%
4/14/2023	Raymond James & Associates	320,622	$0.12M	0.0%	+947.0%	1.229%
11/15/2022	First Manhattan Co.	66,214	$36K	0.0%	-27.4%	0.274%
8/15/2022	Kettle Hill Capital Management LLC	272,447	$0.44M	0.1%	N/A	1.193%
7/27/2022	Bailard Inc.	20,285	$33K	0.0%	N/A	0.089%
5/10/2022	Smith Salley & Associates	11,000	$46K	0.0%	N/A	0.048%
4/12/2022	CAPROCK Group Inc.	56,582	$0.24M	0.0%	N/A	0.248%
2/11/2022	M28 Capital Management LP	133,442	$0.62M	0.5%	N/A	0.588%
2/9/2022	First Republic Investment Management Inc.	100,000	$0.46M	0.0%	N/A	0.440%
2/4/2022	TimesSquare Capital Management LLC	216,391	$1M	0.0%	-52.4%	0.953%
2/2/2022	New York State Common Retirement Fund	9,259	$43K	0.0%	+60.5%	0.041%
11/17/2021	ArrowMark Colorado Holdings LLC	1,958,813	$29.66M	0.2%	-23.1%	8.625%
11/16/2021	Suvretta Capital Management LLC	344,223	$5.21M	0.1%	-5.9%	1.521%
11/16/2021	Metropolitan Life Insurance Co NY	5,828	$88K	0.0%	N/A	0.026%
11/15/2021	683 Capital Management LLC	100,687	$1.52M	0.1%	+67.8%	0.445%
11/15/2021	Kingdon Capital Management L.L.C.	117,962	$1.79M	0.2%	N/A	0.521%
11/15/2021	First Manhattan Co.	147,159	$2.23M	0.0%	N/A	0.650%
11/12/2021	Rockefeller Capital Management L.P.	27,860	$0.42M	0.0%	N/A	0.123%
11/12/2021	The Manufacturers Life Insurance Company	10,464	$0.16M	0.0%	N/A	0.046%
11/12/2021	Geode Capital Management LLC	212,431	$3.22M	0.0%	+87.4%	0.939%
11/12/2021	Edgewood Management LLC	56,015	$0.85M	0.0%	N/A	0.248%
11/10/2021	Citigroup Inc.	3,335	$50K	0.0%	+935.7%	0.015%
11/9/2021	BlackRock Inc.	812,664	$12.30M	0.0%	+150.4%	3.591%
11/8/2021	TimesSquare Capital Management LLC	454,550	$6.88M	0.1%	-5.7%	2.009%
11/4/2021	Deutsche Bank AG	10,149	$0.15M	0.0%	+159.6%	0.045%
11/2/2021	Raymond James & Associates	25,957	$0.39M	0.0%	N/A	0.115%
11/1/2021	SG Americas Securities LLC	7,524	$0.11M	0.0%	N/A	0.033%
8/17/2021	Walleye Capital LLC	32,140	$0.53M	0.0%	-19.7%	0.142%
8/17/2021	ArrowMark Colorado Holdings LLC	2,547,993	$2.13M	0.0%	-1.7%	11.260%
8/16/2021	Alyeska Investment Group L.P.	11,417	$0.19M	0.0%	-84.8%	0.050%
8/16/2021	Charles Schwab Investment Management Inc.	41,670	$0.68M	0.0%	-7.0%	0.184%
8/16/2021	State Street Corp	95,714	$1.56M	0.0%	+97.5%	0.423%
8/13/2021	Northern Trust Corp	68,941	$1.13M	0.0%	-1.3%	0.305%
8/13/2021	Geode Capital Management LLC	113,336	$1.85M	0.0%	+11.1%	0.501%
8/13/2021	Vanguard Group Inc.	361,278	$5.90M	0.0%	+75.2%	1.597%
8/12/2021	JPMorgan Chase & Co.	273,434	$4.46M	0.0%	+69.2%	1.211%
8/11/2021	Bank of New York Mellon Corp	18,240	$0.30M	0.0%	+31.0%	0.081%
8/11/2021	BlackRock Inc.	324,524	$5.30M	0.0%	+6.9%	1.437%
8/9/2021	TimesSquare Capital Management LLC	482,100	$7.87M	0.1%	-1.0%	2.135%
8/4/2021	Russell Investments Group Ltd.	2,432	$39K	0.0%	N/A	0.011%
5/18/2021	Baker BROS. Advisors LP	294,117	$5.61M	0.0%	N/A	1.292%
5/18/2021	Millennium Management LLC	105,407	$2.01M	0.0%	N/A	0.463%
5/18/2021	Alyeska Investment Group L.P.	75,000	$1.43M	0.0%	N/A	0.330%
5/18/2021	Jane Street Group LLC	13,226	$0.25M	0.0%	N/A	0.058%
5/18/2021	California State Teachers Retirement System	9,656	$0.18M	0.0%	N/A	0.042%
5/17/2021	Suvretta Capital Management LLC	579,283	$11.05M	0.2%	N/A	2.545%
5/17/2021	Walleye Capital LLC	40,000	$0.76M	0.0%	N/A	0.176%
5/17/2021	683 Capital Management LLC	60,000	$1.15M	0.1%	N/A	0.264%
5/17/2021	HBK Investments L P	30,000	$0.57M	0.0%	N/A	0.132%
5/17/2021	Allen Operations LLC	635,934	$12.13M	2.5%	N/A	2.794%
5/17/2021	DSAM Partners London Ltd	89,500	$1.71M	0.3%	N/A	0.393%
5/17/2021	Nuveen Asset Management LLC	10,368	$0.20M	0.0%	N/A	0.046%
5/14/2021	Bridger Management LLC	400,000	$7.63M	0.7%	N/A	1.758%
5/13/2021	Bank of New York Mellon Corp	13,925	$0.27M	0.0%	N/A	0.061%
5/12/2021	Northern Trust Corp	69,871	$1.33M	0.0%	N/A	0.307%
5/12/2021	Geode Capital Management LLC	101,977	$1.95M	0.0%	N/A	0.448%
5/12/2021	JPMorgan Chase & Co.	161,640	$3.08M	0.0%	N/A	0.710%
5/12/2021	UBS Group AG	1,883	$36K	0.0%	N/A	0.008%
5/12/2021	TimesSquare Capital Management LLC	487,100	$9.29M	0.1%	N/A	2.140%
5/11/2021	New York State Common Retirement Fund	5,700	$0.11M	0.0%	N/A	0.025%
5/7/2021	BlackRock Inc.	303,497	$5.79M	0.0%	N/A	1.334%
5/7/2021	American International Group Inc.	3,731	$71K	0.0%	N/A	0.016%
5/4/2021	Victory Capital Management Inc.	11,045	$0.21M	0.0%	N/A	0.049%

Data available starting January 2016

NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases in the United States. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a product candidate targeted against HPV related cancers, which is in Phase I/II clinical trials. It provides NEXI-004 which is in preclinical stage for EBV related diseases; and NEXI005 designs for patient with specific targets for solid tumors. NexImmune, Inc. was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.

Today's Range

Now: N/A

50 Day Range

MA: $0.09

$0.00

$0.16

52 Week Range

Now: N/A

Volume

N/A

Average Volume

11,509 shs

Market Capitalization

N/A

P/E Ratio

N/A

Dividend Yield

N/A

Beta

2.12

Who are the company insiders with the largest holdings of NexImmune?: NexImmune's top insider investors include:
Sol J Barer (Director)
Alan S Roemer (Director)
Kristi Jones (CEO)
Learn More about top insider investors at NexImmune.